Pembrolizumab trials for Stage III Lung Cancer AJCC v8

All Pembrolizumab trials · All Stage III Lung Cancer AJCC v8 trials

Phase breakdown

Recruiting trials studying Pembrolizumab for Stage III Lung Cancer AJCC v8

• Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy
  NCT06731270 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer
  NCT07017829 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
  NCT05269381 · Phase: Phase 1, Phase 2 · Ages: 16 Years and older · Sex: All (male and female) · 2 locations

Common questions

How many trials study Pembrolizumab for Stage III Lung Cancer AJCC v8?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.